156 related articles for article (PubMed ID: 29581542)
1. Detailed genomic characterization identifies high heterogeneity and histotype-specific genomic profiles in adrenocortical carcinomas.
Vatrano S; Volante M; Duregon E; Giorcelli J; Izzo S; Rapa I; Votta A; Germano A; Scagliotti G; Berruti A; Terzolo M; Papotti AM
Mod Pathol; 2018 Aug; 31(8):1257-1269. PubMed ID: 29581542
[TBL] [Abstract][Full Text] [Related]
2. Targeted Molecular Analysis in Adrenocortical Carcinomas: A Strategy Toward Improved Personalized Prognostication.
Lippert J; Appenzeller S; Liang R; Sbiera S; Kircher S; Altieri B; Nanda I; Weigand I; Gehrig A; Steinhauer S; Riemens RJM; Rosenwald A; Müller CR; Kroiss M; Rost S; Fassnacht M; Ronchi CL
J Clin Endocrinol Metab; 2018 Dec; 103(12):4511-4523. PubMed ID: 30113656
[TBL] [Abstract][Full Text] [Related]
3. Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma.
Juhlin CC; Goh G; Healy JM; Fonseca AL; Scholl UI; Stenman A; Kunstman JW; Brown TC; Overton JD; Mane SM; Nelson-Williams C; Bäckdahl M; Suttorp AC; Haase M; Choi M; Schlessinger J; Rimm DL; Höög A; Prasad ML; Korah R; Larsson C; Lifton RP; Carling T
J Clin Endocrinol Metab; 2015 Mar; 100(3):E493-502. PubMed ID: 25490274
[TBL] [Abstract][Full Text] [Related]
4. Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape.
Fojo T; Huff L; Litman T; Im K; Edgerly M; Del Rivero J; Pittaluga S; Merino M; Bates SE; Dean M
BMC Med Genomics; 2020 Nov; 13(1):165. PubMed ID: 33148256
[TBL] [Abstract][Full Text] [Related]
5. Myxoid adrenocortical neoplasms: a study of the clinicopathologic features and EGFR gene status of ten Chinese cases.
Zhang J; Sun J; Liang Z; Gao J; Zeng X; Liu T
Am J Clin Pathol; 2011 Nov; 136(5):783-92. PubMed ID: 22031318
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations.
Duregon E; Rapa I; Votta A; Giorcelli J; Daffara F; Terzolo M; Scagliotti GV; Volante M; Papotti M
Hum Pathol; 2014 Aug; 45(8):1555-62. PubMed ID: 24890943
[TBL] [Abstract][Full Text] [Related]
7. Adrenocortical tumors have a distinct, long, non-coding RNA expression profile and LINC00271 is downregulated in malignancy.
Buishand FO; Liu-Chittenden Y; Fan Y; Tirosh A; Gara SK; Patel D; Meerzaman D; Kebebew E
Surgery; 2020 Jan; 167(1):224-232. PubMed ID: 31522749
[TBL] [Abstract][Full Text] [Related]
8. TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical Carcinomas.
Gupta S; Won H; Chadalavada K; Nanjangud GJ; Chen YB; Al-Ahmadie HA; Fine SW; Sirintrapun SJ; Strong VE; Raj N; Lagunes DR; Vanderbilt CM; Berger MF; Ladanyi M; Dogan S; Tickoo SK; Reuter VE; Gopalan A
Endocr Pathol; 2022 Jun; 33(2):304-314. PubMed ID: 34549366
[TBL] [Abstract][Full Text] [Related]
9. Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis.
Papathomas TG; Duregon E; Korpershoek E; Restuccia DF; van Marion R; Cappellesso R; Sturm N; Rossi G; Coli A; Zucchini N; Stoop H; Oosterhuis W; Ventura L; Volante M; Fassina A; Dinjens WN; Papotti M; de Krijger RR
Hum Pathol; 2016 Dec; 58():113-122. PubMed ID: 27589897
[TBL] [Abstract][Full Text] [Related]
10. Mass-array screening of frequent mutations in cancers reveals RB1 alterations in aggressive adrenocortical carcinomas.
Ragazzon B; Libé R; Assié G; Tissier F; Barreau O; Houdayer C; Perlemoine K; Audebourg A; Clauser E; René-Corail F; Bertagna X; Dousset B; Bertherat J; Groussin L
Eur J Endocrinol; 2014 Mar; 170(3):385-91. PubMed ID: 24347427
[TBL] [Abstract][Full Text] [Related]
11. Targeted genomic analysis of 364 adrenocortical carcinomas.
Pozdeyev N; Fishbein L; Gay LM; Sokol ES; Hartmaier R; Ross JS; Darabi S; Demeure MJ; Kar A; Foust LJ; Koc K; Bowles DW; Leong S; Wierman ME; Kiseljak-Vassiliades K
Endocr Relat Cancer; 2021 Aug; 28(10):671-681. PubMed ID: 34410225
[TBL] [Abstract][Full Text] [Related]
12. ENDOCRINE TUMOURS: The genomics of adrenocortical tumors.
Faillot S; Assie G
Eur J Endocrinol; 2016 Jun; 174(6):R249-65. PubMed ID: 26739091
[TBL] [Abstract][Full Text] [Related]
13. Integrated genomic characterization of adrenocortical carcinoma.
Assié G; Letouzé E; Fassnacht M; Jouinot A; Luscap W; Barreau O; Omeiri H; Rodriguez S; Perlemoine K; René-Corail F; Elarouci N; Sbiera S; Kroiss M; Allolio B; Waldmann J; Quinkler M; Mannelli M; Mantero F; Papathomas T; De Krijger R; Tabarin A; Kerlan V; Baudin E; Tissier F; Dousset B; Groussin L; Amar L; Clauser E; Bertagna X; Ragazzon B; Beuschlein F; Libé R; de Reyniès A; Bertherat J
Nat Genet; 2014 Jun; 46(6):607-12. PubMed ID: 24747642
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.
Zheng S; Cherniack AD; Dewal N; Moffitt RA; Danilova L; Murray BA; Lerario AM; Else T; Knijnenburg TA; Ciriello G; Kim S; Assie G; Morozova O; Akbani R; Shih J; Hoadley KA; Choueiri TK; Waldmann J; Mete O; Robertson AG; Wu HT; Raphael BJ; Shao L; Meyerson M; Demeure MJ; Beuschlein F; Gill AJ; Sidhu SB; Almeida MQ; Fragoso MCBV; Cope LM; Kebebew E; Habra MA; Whitsett TG; Bussey KJ; Rainey WE; Asa SL; Bertherat J; Fassnacht M; Wheeler DA; ; Hammer GD; Giordano TJ; Verhaak RGW
Cancer Cell; 2016 May; 29(5):723-736. PubMed ID: 27165744
[TBL] [Abstract][Full Text] [Related]
15. Dissecting Morphological and Molecular Heterogeneity in Adrenocortical Carcinoma.
Duregon E; Volante M; Rapa I; Vatrano S; Papotti M
Turk Patoloji Derg; 2015; 31 Suppl 1():98-104. PubMed ID: 26177320
[TBL] [Abstract][Full Text] [Related]
16. Adrenocortical carcinoma: review and update.
Erickson LA; Rivera M; Zhang J
Adv Anat Pathol; 2014 May; 21(3):151-9. PubMed ID: 24713984
[TBL] [Abstract][Full Text] [Related]
17. CCNB2 and AURKA overexpression may cause atypical mitosis in Japanese cortisol-producing adrenocortical carcinoma with TP53 somatic variant.
Ikeya A; Nakashima M; Yamashita M; Kakizawa K; Okawa Y; Saitsu H; Sasaki S; Sasano H; Suda T; Oki Y
PLoS One; 2020; 15(4):e0231665. PubMed ID: 32287321
[TBL] [Abstract][Full Text] [Related]
18. Advances in understanding the molecular underpinnings of adrenocortical tumors.
Nicolson NG; Man J; Carling T
Curr Opin Oncol; 2018 Jan; 30(1):16-22. PubMed ID: 29028646
[TBL] [Abstract][Full Text] [Related]
19. Molecular screening for a personalized treatment approach in advanced adrenocortical cancer.
De Martino MC; Al Ghuzlan A; Aubert S; Assié G; Scoazec JY; Leboulleux S; Do Cao C; Libè R; Nozières C; Lombès M; Pattou F; Borson-Chazot F; Hescot S; Mazoyer C; Young J; Borget I; Colao A; Pivonello R; Soria JC; Bertherat J; Schlumberger M; Lacroix L; Baudin E
J Clin Endocrinol Metab; 2013 Oct; 98(10):4080-8. PubMed ID: 23979958
[TBL] [Abstract][Full Text] [Related]
20. Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies.
Ross JS; Wang K; Rand JV; Gay L; Presta MJ; Sheehan CE; Ali SM; Elvin JA; Labrecque E; Hiemstra C; Buell J; Otto GA; Yelensky R; Lipson D; Morosini D; Chmielecki J; Miller VA; Stephens PJ
J Clin Pathol; 2014 Nov; 67(11):968-73. PubMed ID: 25078331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]